小林製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 化学 | 4967/E01047 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2012/03/02 | 日証協 | 187,878株 | +2.29% | 54,243株 | -49.2% | 276,227株 | -4.2% | 154,400株 | +10.57% |
2012/02/24 | 日証協 | 183,678株 | +6.68% | 106,774株 | +16.28% | 288,327株 | +0.7% | 139,635株 | -38.69% |
2012/02/17 | 日証協 | 172,176株 | +4.59% | 91,821株 | -37.27% | 286,327株 | +1.92% | 227,735株 | -30.23% |
2012/02/10 | 日証協 | 164,626株 | +32.57% | 146,365株 | +87.86% | 280,927株 | +19.95% | 326,400株 | +40.5% |
2012/02/03 | 日証協 | 124,176株 | +22.67% | 77,911株 | +64.05% | 234,206株 | +27.06% | 232,307株 | +444.4% |
2012/01/27 | 日証協 | 101,226株 | +7.12% | 47,493株 | +55.27% | 184,327株 | -5.04% | 42,672株 | -51.88% |
2012/01/20 | 日証協 | 94,502株 | -5.12% | 30,588株 | -38.51% | 194,103株 | +9.14% | 88,683株 | +62.55% |
2012/01/13 | 日証協 | 99,600株 | +5.63% | 49,748株 | +118.1% | 177,851株 | -7.94% | 54,559株 | +61.85% |
2012/01/06 | 日証協 | 94,288株 | -3.92% | 22,810株 | -72.43% | 193,192株 | +1.07% | 33,709株 | -64.75% |
2011/12/30 | 日証協 | 98,138株 | -8.94% | 82,740株 | +101.93% | 191,142株 | -11.87% | 95,641株 | +12.2% |
2011/12/22 | 日証協 | 107,778株 | -1.15% | 40,975株 | +39.24% | 216,877株 | -0.39% | 85,241株 | -33.59% |
2011/12/16 | 日証協 | 109,028株 | +0.52% | 29,427株 | -8.76% | 217,727株 | +11.29% | 128,352株 | -14.94% |
2011/12/09 | 日証協 | 108,469株 | +34.21% | 32,254株 | +26.73% | 195,643株 | +15.53% | 150,902株 | +177.52% |
2011/12/02 | 日証協 | 80,819株 | -24.52% | 25,450株 | +60.06% | 169,347株 | -11.59% | 54,376株 | -15.53% |
2011/11/25 | 日証協 | 107,069株 | +8.84% | 15,900株 | +80.68% | 191,547株 | +0.26% | 64,374株 | +26.17% |
2011/11/18 | 日証協 | 98,369株 | +0.06% | 8,800株 | -81.11% | 191,047株 | +3.41% | 51,022株 | -21.35% |
2011/11/11 | 日証協 | 98,306株 | -25.21% | 46,585株 | -10.59% | 184,747株 | -22.3% | 64,870株 | -57.69% |
2011/11/04 | 日証協 | 131,441株 | +1.08% | 52,105株 | -52.8% | 237,780株 | +14.14% | 153,323株 | +48.61% |
2011/10/28 | 日証協 | 130,040株 | -15.47% | 110,392株 | +74.09% | 208,326株 | -20.25% | 103,172株 | -5.22% |
※株式分割は考慮していませんのでご注意ください。
Page Top